Insider Holders & Insider Ownership - Chemomab Therapeutics Ltd. (CMMB)

List of insiders holdings for Chemomab Therapeutics Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
THIEL PETER
10% Owner
2021-03-26 08:10:0722,631,260
0
22,631,260Form 13G
Access Industries Holdings LLC
Clal Biotechnology Industries Ltd.
ACCESS INDUSTRIES LLC
ACCESS INDUSTRIES MANAGEMENT LLC
Blavatnik Len
10% Owner
2021-04-15 17:28:035,057,766
0
5,057,766Form 13D
Gabriel Capital Management Ltd.
10% Owner
2022-02-10 16:02:583,087,040
0
3,087,040Form 13G
Haluska Frank
Chief Executive Officer
2020-01-02 16:33:582,148,236
0
2,148,236Form 3
OrbiMed Israel GP Ltd.
OrbiMed Israel BioFund GP Limited Partnership
10% Owner
2024-09-16 16:34:031,860,906
0
1,860,906Form 13D
Mor George Adi
Chief Scientific Officer
2023-01-05 16:01:17448,773
284,872
733,645Form 4
Pfost Dale R
Chief Executive Officer
2022-03-15 16:10:10461,853
0
461,853Form 4
VERU DENNISON T
Director
2020-01-02 16:34:2181,900
369,640
451,540Form 3
Burgin Jonathan
See Remarks
2020-01-02 16:34:45340,037
0
340,037Form 3
Kerstein David
Chief Medical Officer
2020-01-02 16:31:04340,000
0
340,000Form 3
Fatal Sigal
Chief Financial Officer
2023-06-16 16:03:05273,669
0
273,669Form 4
Knickerbocker Ron
See Remarks
2020-01-02 16:32:13235,000
0
235,000Form 3
Marvin Donald
Executive VP, CFO & COO
2022-06-21 06:01:38198,875
0
198,875Form 4
SQUINTO STEPHEN P
Director
2021-04-21 17:16:57168,624
0
168,624Form 4
Frankel Matthew Bejosa
Chief Medical Officer
2022-11-15 16:03:38125,000
0
125,000Form 3
Gilon Ohev-Zion Michal
VP, Research and Development
2020-01-02 16:33:35100,254
0
100,254Form 3
Daly Sean T
VP, Clinical Operations
2020-01-02 16:32:4480,000
0
80,000Form 3
Aharon Arnon
Chief Medical Officer
2021-03-25 10:11:2175,232
0
75,232Form 3
HOWARD LAWRENCE
Director
2020-01-02 16:30:4055,000
15,385
70,385Form 3
Darvish Nissim
Director
2023-07-05 17:48:4357,456
0
57,456Form 4
Alon Ruth
Director
2020-01-02 16:35:0855,353
0
55,353Form 3
Makov Efrat
Director
2020-01-02 16:31:2555,353
0
55,353Form 3
Polovets Stanislav
Director
2021-03-12 16:28:0555,000
0
55,000Form 4
HARDY REGINALD L
Director
2020-01-02 16:35:3055,000
0
55,000Form 3
Kohlberg Isaac T.
Director
2020-01-02 16:31:5155,000
0
55,000Form 3
Cohen Neil Harris
Director
2023-03-23 07:35:3136,267
0
36,267Form 4
Quigley Jill M.
Director
2023-06-20 06:03:0334,137
0
34,137Form 4
Roshan Salar
Head of Business Development
2020-01-02 16:33:0630,000
0
30,000Form 3
Nicaise Claude
Director
2023-03-23 07:36:5825,561
0
25,561Form 4
Moses Alan Charles
Director
2023-03-23 07:38:4225,561
0
25,561Form 4
Maryles Joel Michael
Director
2022-05-25 16:03:5020,137
0
20,137Form 4
Fine Andrew
Chief Financial Officer
2021-03-11 18:34:090
0
0Form 3
DiPalma Stephen J.
Chief Financial Officer
2020-05-07 16:16:210
0
0Form 3
Gonen Ofer
Director
2020-01-02 17:08:410
0
0Form 3